:00:35
You have cancer.
:00:37
Miss Bearing, you have
advanced metastatic ovarian cancer.
:00:45
Go on.
:00:47
- You are a professor, Miss Bearing.
- Like yourself, Dr. Kelekian.
:00:51
Why, yes.
:00:53
Now then, you present with a growth
that unfortunately went undetected...
:00:57
in stages one, two, and three.
:00:59
- Now it is an insidious adenocarcinoma...
- Insidious?
:01:03
Insidious means undetectable at an early...
:01:05
Insidious means treacherous.
:01:08
- Shall I continue?
- By all means.
:01:11
Good.
:01:12
In invasive epithelial carcinoma...
:01:14
the most effective treatment modality
is a chemotherapeutic agent.
:01:18
We are developing
an experimental combination of drugs...
:01:21
designed for primary-site ovarian,
for the target specificity of stage three...
:01:25
and beyond administration.
:01:27
Am I going too fast?
:01:29
No.
:01:32
You will be hospitalized
as an in-patient for treatment each cycle.
:01:32
You will be hospitalized
as an in-patient for treatment each cycle.
:01:36
After the initial eight cycles,
you will have another battery of tests.
:01:40
The antineoplastic will inevitably
affect some healthy cells...
:01:44
including those lining
the gastrointestinal tract...
:01:46
from the lips to the anus,
and the hair follicles.
:01:48
We will be relying on your resolve...
:01:50
to withstand some of the more
pernicious side effects.
:01:58
I beg your pardon.